The increasing number of COVID-19 cases in Indonesia has made the target number of examining PCR specimens to continue to grow, from 30,000 to 50,000 samples per day. However, this target has not been achieved due to several obstacles. In addition to the insufficient number of trained personnel, PCR facilities and available equipment are also still at the minimum.
Fullerton Health Group, Indonesia, in its contribution to the government’s efforts to deal with the spread of the Corona virus, continues to develop itself, this time by adding PCR equipment at Tirta Medical Centre laboratories, one of Fullerton Health subsidiaries in Indonesia, which are located in several cities in Indonesia.
This increase in the number of devices are offset by a fast analysis cycle because it is supported by robotic machines, Laboratory Information Management Systems, and trained personnel to produce fast but validated results.
With a sample processing capacity of up to 5,000 per day, besides serving the public & corporations, the laboratories also accept sample referrals from other health facilities (hospitals, clinics, and other clinical laboratories). Currently, Tirta Medical Centre operates 5 PCR labs in Jakarta, Balikpapan, Banjarmasin, Berau, and Angsana (Kalimantan), while PCR test sampling can be done at 15 clinic locations and more than 3,000 networks of medical facilities throughout Indonesia.
In addition to the locations above, PCR tests can be performed at the patient’s location (onsite / homecare), or by activating the Mobile PCR unit.
